SunWay Biotech Co., Ltd.(TW:1271)
NT$58.80+0.80 (+1.38%)
TW:1271
SunWay Biotech Co., Ltd. Revenue
NT$58.80
At close:+0.80 (+1.38%)
SunWay Biotech Co., Ltd. (1271) Revenue
SunWay Biotech Co., Ltd. Revenue
SunWay Biotech Co., Ltd. had a revenue of 1.01B in the quarter ending Jun 30, 2026, with 90.22%. This bring the company's revenue in the last twelve months to 1.54B, Increased 54.55%. In the fiscal year ending Dec 31, 2025, SunWay Biotech Co., Ltd. had annual revenue of 993.30M with 2.38% growth.
- Revenue (ttm)
- 1.54B
- Revenue Growth
- 61.34%
- P/S Ratio
- 4.56
- Revenue/Employee
- TWD 17,125,914
- Employees
- 58
- Market Cap
- TWD 4.53B
Revenue Chart
SunWay Biotech Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 993.30M | 23.12M | 2.38% |
| Dec 31, 2024 | 970.18M | 399.07M | 69.88% |
| Dec 31, 2023 | 571.11M | 145.76M | 34.27% |
| Dec 31, 2022 | 425.35M | 44.92M | 11.81% |
| Dec 31, 2021 | 380.43M | 65.96M | 20.97% |
| Dec 31, 2020 | 314.48M | 142.29M | 82.64% |
| Dec 31, 2019 | 172.19M | 63.53M | 58.48% |
| Dec 31, 2018 | 108.65M | 37.26M | 52.19% |
| Dec 31, 2017 | 71.39M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.